{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:37:45Z","timestamp":1770820665151,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To investigate the safety and tolerability of COVID-19 vaccines in people with epilepsy (PwE).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this multicentric observational cohort study, we recruited adult patients (age\u2009&gt;\u200918\u00a0years old) with epilepsy who attended the Outpatient Epilepsy Clinic from 1st July to 30th October 2021. We administered to the patients a structured questionnaire and interview on demographic and epilepsy characteristics, current treatment, previous SARS-CoV-2 infection, vaccine characteristics, post-vaccine seizure relapse, other side effect, variation of sleep habits, caffeine, or alcohol intake. Seizure frequency worsening was defined as a ratio between mean monthly frequency post-vaccination and mean monthly frequency pre-vaccination superior to 1. Patients were categorized in two groups: patients with seizure frequency worsening (WORSE) and patients with seizure stability (STABLE).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 358 people participated with a mean age of 47.46\u2009\u00b1\u200919.04. Focal seizure (79.1%), generalized epilepsy (20.4%), and unknown types of epilepsy (0.5%) were detected among participants. In total, 31 (8.7%) people expressed that they were not willing to receive a COVID-19 vaccine; 302 patients (92.35%) did not experience an increase in the seizure frequency (STABLE-group) whereas 25 patients (7.65%) had a seizure worsening (WORSE-group). Post-vaccine seizures occurred mainly in the 7\u00a0days following the administration of the vaccine. Patients in the WORSE-group were treated with a mean higher number of anti-seizure medication (ASMs) (<jats:italic>p<\/jats:italic>\u2009=\u20090.003) and had a higher pre-vaccine seizure frequency (<jats:italic>p<\/jats:italic>\u2009=\u20090.009) compared with patients in the STABLE-group. Drug-resistant epilepsy was also associated with seizure worsening (<jats:italic>p<\/jats:italic>\u2009=\u20090.01). One-year pre-vaccination seizure frequency pattern demonstrated that patients in the WORSE-group had a higher frequency pattern (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Multivariate analysis of the vaccinated group showed that only the seizure frequency pattern (confidence interval [CI]\u2009=\u20091.257\u20132.028; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) was significantly associated with seizure worsening.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In our cohort of vaccinated PwE, only a little percentage had a transient short-term increase of seizure frequency. The present study demonstrates that COVID-19 vaccines have a good safety and tolerability profile in the short term in PwE.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10072-022-06100-0","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T16:03:22Z","timestamp":1651507402000},"page":"4627-4634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience"],"prefix":"10.1007","volume":"43","author":[{"given":"Marina","family":"Romozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Rollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Quintieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3575-2942","authenticated-orcid":false,"given":"Fedele","family":"Dono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Veleno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Anzellotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Calvello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serenella","family":"Servidei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catello","family":"Vollono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"issue":"3","key":"6100_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL (2021) Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 19(3):141\u2013154","journal-title":"Nat Rev Microbiol"},{"key":"6100_CR2","unstructured":"WHO, Draft landscape of COVID-19 candidate vaccines, World Health Organisation (2020)."},{"issue":"5","key":"6100_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403\u2013416","journal-title":"N Engl J Med"},{"issue":"27","key":"6100_CR4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P\u00e9rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T\u00fcreci \u00d6, Nell H, Schaefer A, \u00dcnal S, Tresnan DB, Mather S, Dormitzer PR, \u015eahin U, Jansen KU, Gruber WC (2020) Gruber, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603\u20132615","journal-title":"N Engl J Med"},{"issue":"10267","key":"6100_CR5","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","volume":"396","author":"MN Ramasamy","year":"2021","unstructured":"Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, Voysey M, Aley PK, Angus B, Babbage G, Belij-Rammerstorfer S, Berry L, Bibi S, Bittaye M, Cathie K, Chappell H, Charlton S, Cicconi P, Clutterbuck EA, Colin-Jones R, Dold C, Emary KRW, Fedosyuk S, Fuskova M, Gbesemete D, Green C, Hallis B, Hou MM, Jenkin D, Joe CCD, Kelly EJ, Kerridge S, Lawrie AM, Lelliott A, Lwin MN, Makinson R, Marchevsky NG, Mujadidi Y, Munro APS, Pacurar M, Plested E, Rand J, Rawlinson T, Rhead S, Robinson H, Ritchie AJ, Ross-Russell AL, Saich S, Singh N, Smith CC, Snape MD, Song R, Tarrant R, Themistocleous Y, Thomas KM, Villafana TL, Warren SC, Watson MEE, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Faust SN, Pollard AJ (2021) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial. Lancet 396(10267):1979\u20131993","journal-title":"Lancet"},{"issue":"9","key":"6100_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMoa003077","volume":"345","author":"WE Barlow","year":"2001","unstructured":"Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N (2001) The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 345(9):656\u2013661","journal-title":"N Engl J Med"},{"issue":"2","key":"6100_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/WCO.0b013e3280555160","volume":"20","author":"NJ Brown","year":"2007","unstructured":"Brown NJ, Berkovic SF, Scheffer IE (2007) Vaccination, seizures and \u2018vaccine damage.\u2019 Curr Opin Neurol 20(2):181\u2013187","journal-title":"Curr Opin Neurol"},{"issue":"Suppl 7","key":"6100_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/epi.12306","volume":"54","author":"D Pruna","year":"2013","unstructured":"Pruna D, Balestri P, Zamponi N, Grosso S, Gobbi G, Romeo A, Franzoni E, Osti M, Capovilla G, Longhi R, Verrotti A (2013) Epilepsy and vaccinations: Italian guidelines. Epilepsia 54(Suppl 7):13\u201322","journal-title":"Epilepsia"},{"issue":"10","key":"6100_CR9","doi-asserted-by":"publisher","first-page":"e1417","DOI":"10.1212\/WNL.0000000000010033","volume":"95","author":"P Cabezudo-Garc\u00eda","year":"2020","unstructured":"Cabezudo-Garc\u00eda P, Ciano-Petersen NL, Mena-V\u00e1zquez N, Pons-Pons G, Castro-S\u00e1nchez MV, Serrano-Castro PJ (2020) Incidence and case fatality rate of COVID-19 in patients with active epilepsy. Neurology 95(10):e1417\u2013e1425","journal-title":"Neurology"},{"issue":"2","key":"6100_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5664\/jcsm.5498","volume":"12","author":"DL Reed","year":"2016","unstructured":"Reed DL, Sacco WP (2016) Measuring sleep efficiency: what should the denominator be? J Clin Sleep Med 12(2):263\u2013266","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"6100_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000066239","volume":"31","author":"P Richter","year":"1998","unstructured":"Richter P, Werner J, Heerlein A, Kraus A, Sauer H (1998) On the validity of the Beck Depression Inventory. Rev Psychopathol 31(3):160\u2013168","journal-title":"Rev Psychopathol"},{"issue":"4","key":"6100_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/epi.13670","volume":"58","author":"RS Fisher","year":"2017","unstructured":"Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, Lagae L, Mosh\u00e9 SL, Peltola J, Roulet Perez E, Scheffer IE, Zuberi SM (2017) Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58(4):522\u2013530","journal-title":"Epilepsia"},{"key":"6100_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1751-0473-3-17","volume":"3","author":"Z Bursac","year":"2008","unstructured":"Bursac Z, Gauss CH, Williams DK, Hosmer DW (2008) Purposeful selection of variables in logistic regression. Sour Code Biol Med 3:17\u201317","journal-title":"Sour Code Biol Med"},{"key":"6100_CR14","doi-asserted-by":"crossref","unstructured":"L Lu, Q Zhang, J Xiao, Y Zhang, W Peng, X Han, S Chen, D Yang, JW Sander, D Zhou, W Xiong (2021). COVID-19 vaccine take-up rate and safety in adults with epilepsy: dData from a multicenter study in China, Epilepsia","DOI":"10.1111\/epi.17138"},{"key":"6100_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.seizure.2021.08.001","volume":"92","author":"F Massoud","year":"2021","unstructured":"Massoud F, Ahmad SF, Hassan AM, Alexander KJ, Al-Hashel J, Arabi M (2021) Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): a cross-sectional study. Seizure 92:2\u20139","journal-title":"Seizure"},{"key":"6100_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108160","volume":"122","author":"R von Wrede","year":"2021","unstructured":"von Wrede R, Pukropski J, Moskau-Hartmann S, Surges R, Baumgartner T (2021) COVID-19 vaccination in patients with epilepsy: first experiences in a German tertiary epilepsy center. Epilepsy Behav 122:108160","journal-title":"Epilepsy Behav"},{"key":"6100_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7594","volume":"345","author":"L Arnheim-Dahlstr\u00f6m","year":"2012","unstructured":"Arnheim-Dahlstr\u00f6m L, H\u00e4llgren J, Weibull CE, Spar\u00e9n P (2012) Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study. BMJ 345:e7594","journal-title":"BMJ"},{"issue":"3","key":"6100_CR18","first-page":"221","volume":"23","author":"K Xing","year":"2021","unstructured":"Xing K, Tu XY, Liu M, Liang ZW, Chen JN, Li JJ, Jiang LG, Xing FQ, Jiang Y (2021) Efficacy and safety of COVID-19 vaccines: a systematic review. Zhongguo Dang Dai Er Ke Za Zhi 23(3):221\u2013228","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"6100_CR19","doi-asserted-by":"crossref","unstructured":"N Li, C Chu, W Lin (2021) A survey of hesitancy and response to the COVID-19 vaccine among patients with epilepsy in Northeast China, Front Neurol 12(2049)","DOI":"10.3389\/fneur.2021.778618"},{"key":"6100_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.seizure.2021.01.021","volume":"86","author":"CS Kow","year":"2021","unstructured":"Kow CS, Hasan SS (2021) Potential interactions between COVID-19 vaccines and antiepileptic drugs. Seizure 86:80\u201381","journal-title":"Seizure"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06100-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06100-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06100-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T03:29:55Z","timestamp":1661138995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06100-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6100"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06100-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}